Trial no.:
|
PACTR202202483221034 |
Date of Approval:
|
16/02/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Ultrasound Assessment of Diaphragmatic Movement Post Selective Superior Trunk Block versus Conventional Interscalene Block in Shoulder Arthroscopy |
Official scientific title |
Ultrasound Assessment of Diaphragmatic Movement Post Selective Superior Trunk Block versus Conventional Interscalene Block in Shoulder Arthroscopy |
Brief summary describing the background
and objectives of the trial
|
Shoulder surgery is one of the most common ambulatory orthopedic procedures, with more than 500,000 estimated cases performed each year in the United States alone. Advances in arthroscopic techniques have resulted in decreased recovery times and complication rates . However, postoperative analgesia continues to pose a major challenge, with 20% of patients reporting maximum pain scores on the first postoperative day after being discharged home. (1)
Symptoms have been effectively managed with interscalene block (ISB). But its benefits have usually been offset by high rates of hemi diaphragmatic paralysis (HDP) via unintentional phrenic nerve blockade . (2) This side effect may not be a problem to healthy patients, but it can be very critical in patients with pre-existing pulmonary pathology.(3)
The superior trunk block was described by Burckett-St. Laurent et al. as a refinement of the conventional interscalene block technique. The superior trunk is formed by the fusion of C5and C6 nerve roots, and therefore local anesthetic injection around the superior trunk should produce similar analgesia of the shoulder because all the terminal nerves innervating the shoulder arise distal to the superior trunk. Moreover, the site of injection is further away from the phrenic nerve, and this should theoretically reduce the risk of hemi diaphragmatic paralysis. (4)
Therefore‚ we will design the present randomized, clinical trial to investigate whether the superior trunk block will reduce hemi diaphragmatic paresis in patients undergoing arthroscopic shoulder surgery or not. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
13/02/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
01/05/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
68 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|